Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata.
Renert-Yuval Y, Pavel AB, Del Duca E, Facheris P, Pagan AD, Bose S, Gómez-Arias PJ, Angelov M, Bares J, Chima M, Estrada YD, Garcet S, Lebwohl MG, Krueger JG, Guttman-Yassky E.
Renert-Yuval Y, et al. Among authors: bares j.
Allergy. 2023 Apr;78(4):1047-1059. doi: 10.1111/all.15561. Epub 2022 Nov 5.
Allergy. 2023.
PMID: 36271804
Clinical Trial.